PubMed

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.

Tebib J, Mariette X, Bourgeois P, Flipo RM, Gaudin P, Le Loët X, Gineste P, Guy L, Mansfield CD, Moussy A, Dubreuil P, Hermine O, Sibilia J.

Arthritis Res Ther. 2009;11(3):R95. Epub 2009 Jun 23.PMID: 19549290 [PubMed - in process]Related articlesFree article

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.

Fleischmann R, Vencovsky J, van Vollenhoven RF, Borenstein D, Box J, Coteur G, Goel N, Brezinschek HP, Innes A, Strand V.

Ann Rheum Dis. 2009 Jun;68(6):805-11. Epub 2008 Nov 17.PMID: 19015206 [PubMed - indexed for MEDLINE]Related articlesFree article

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.PMID: 19480470 [PubMed - indexed for MEDLINE]Related articles

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators.

Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26. Erratum in: Lancet. 2009 Oct 24;374(9699):1422. PMID: 19560810 [PubMed - indexed for MEDLINE]Related articles

Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.

Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J.

Rheumatology (Oxford). 2005 Sep;44(9):1140-4. Epub 2005 May 31.PMID: 15927997 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.

Burmester GR, Mariette X, Montecucco C, Monteagudo-Sáez I, Malaise M, Tzioufas AG, Bijlsma JW, Unnebrink K, Kary S, Kupper H.

Ann Rheum Dis. 2007 Jun;66(6):732-9. Epub 2007 Feb 28.PMID: 17329305 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of Prosorba column apheresis in patients with chronic refractory rheumatoid arthritis.

Roth S.

J Rheumatol. 2004 Nov;31(11):2131-5.PMID: 15517623 [PubMed - indexed for MEDLINE]Related articles

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ.

Arthritis Rheum. 2008 Oct;58(10):2968-80.PMID: 18821691 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Genovese MC, Mease PJ, Thomson GT, Kivitz AJ, Perdok RJ, Weinberg MA, Medich J, Sasso EH; M02-570 Study Group.

J Rheumatol. 2007 May;34(5):1040-50. Epub 2007 Apr 15. Erratum in: J Rheumatol. 2007 Jun;34(6):1439. PMID: 17444593 [PubMed - indexed for MEDLINE]Related articles

Masitinib for the treatment of canine atopic dermatitis: a pilot study.

Daigle J, Moussy A, Mansfield CD, Hermine O.

Vet Res Commun. 2010 Jan;34(1):51-63. Epub 2009 Dec 23.PMID: 20033487 [PubMed - in process]Related articles

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.

Genovese MC, Schiff M, Luggen M, Becker JC, Aranda R, Teng J, Li T, Schmidely N, Le Bars M, Dougados M.

Ann Rheum Dis. 2008 Apr;67(4):547-54. Epub 2007 Oct 5.PMID: 17921185 [PubMed - indexed for MEDLINE]Related articles

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.

Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J.

Ann Rheum Dis. 2009 Oct;68(10):1580-4. Epub 2008 Nov 19.PMID: 19019888 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.

Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.

Arthritis Rheum. 2005 Feb;52(2):554-62.PMID: 15693001 [PubMed - indexed for MEDLINE]Related articlesFree article

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Keystone E, Heijde D, Mason D Jr, Landewé R, Vollenhoven RV, Combe B, Emery P, Strand V, Mease P, Desai C, Pavelka K.

Arthritis Rheum. 2008 Nov;58(11):3319-29. Erratum in: Arthritis Rheum. 2009 May;60(5):1249. PMID: 18975346 [PubMed - indexed for MEDLINE]Related articlesFree article

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.

Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J.

Ann Rheum Dis. 2008 Nov;67(11):1516-23. Epub 2008 Jul 14. Erratum in: Ann Rheum Dis. 2009 Feb;68(2):296. PMID: 18625622 [PubMed - indexed for MEDLINE]Related articles

A multicenter study of leukocytapheresis in rheumatoid arthritis.

Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, Tohma S, Suzuki K, Tominaga M, Kawabe Y, Mine M, Honda S, Tsukano M, Nakamura T, Hidaka T, Eguchi K.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):810-6.PMID: 18173913 [PubMed - indexed for MEDLINE]Related articles

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. Review.PMID: 19108784 [PubMed - indexed for MEDLINE]Related articles

Anakinra for rheumatoid arthritis.

Mertens M, Singh JA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. Review.PMID: 19160248 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis.

Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, Dougados M, Baldassare A, Ferraccioli G, Chubick A, Udell J, Cravets MW, Agarwal S, Cooper S, Magrini F.

Arthritis Rheum. 2007 Dec;56(12):3896-908.PMID: 18050221 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.

Ogrendik M.

Clin Ther. 2009 Aug;31(8):1754-64.PMID: 19808134 [PubMed - indexed for MEDLINE]Related articles